Which invasive treatment strategy is preferred in ST-segment elevation myocardial infarction (STEMI): PCI of the infarct-related artery only or revascularization of all significant lesions?
In which patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI) should we perform thrombectomy?
Which patients after cardiac arrest should undergo urgent coronary angiography? Should they be transported to an intensive care unit (ICU) first or directly to a catheterization laboratory?
How to plan diuretic treatment in patients with heart failure to prevent volume overload? Should the treatment be based on the presence of edema or other symptoms or on B-type natriuretic peptide (BNP) levels?
Should heparin be administered in a patient with myocardial infarction (MI) who is already on long-term oral anticoagulants?
Dr Franz H. Messerli discusses treatment of hypertension in the elderly patients, the idea of setting universal blood pressure targets, and the results of SPRINT in a conversation with Dr Jerzy Gąsowski.
In 2017 ESC guidelines on STEMI management, the presence of RBBB, similarly to LBBB, is now an indication for urgent coronary angiography in patients with symptoms of myocardial ischemia. What is this based on? Should every patient with features of MI and RBBB in ECG undergo urgent coronary angiography? Does it apply only to patients with a new block or also to those with a preexisting block?
What is the optimal treatment of heart failure in patients with preserved, reduced, or mid-range LVEF? Should patients with mid-range LVEF be treated similarly to those with reduced LVEF?
What are the current guidelines for monitoring adverse effects in patients treated with statins?
What are the most common errors in the treatment of dyslipidemia?
English
Polski
Español
українська